You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search


( MYE-doe-STAW-rin )
Exceptional Access Program
  • midostaurin - First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria
Other Name(s): Rydapt™
Appearance: Pale orange capsule

You might also be interested in